Skip to content

The mechanism and optimization of side branch protection for coronary bifurcation single stenting

The mechanism and optimization of side branch protection for coronary bifurcation single stenting

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050735
Enrollment
Unknown
Registered
2021-09-03
Start date
2021-09-30
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary bifurcation lesion

Interventions

case series:Nil

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Coronary bifurcation patients undergoing PCI; 2.All patients were treated with single stenting; 3.Aged 18 to 90 years; 4.Sign the informed consent file.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant and lactating; 2. Have a history of mental illness; 3. Those who died during stent implantation; 4. Those who are allergic to contrast agents, everolimus or other rapamycin derivatives, aspirin, clopidogrel, heparin and lidocaine; 5. Patients with New York class IV cardiac function or left ventricular ejection fraction <30%; 6. Incomplete case data; 7. Patients with a history of malignant tumors with an expected survival period of less than 1 year; 8. The researcher believes that there are any other factors that are not suitable for inclusion or that affect subjects to participate in or complete the study.

Design outcomes

Primary

MeasureTime frame
Side branch opening size;

Secondary

MeasureTime frame
Stent thrombosis;major adverse cardiovascular events;

Countries

China

Contacts

Public ContactZhao Xiaohui

The Second Affiliated Hospital of Army Medical University

doctorzhaoxiaohui@yahoo.com+86 13508332848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026